Talia Green joined the MJ team as an analytics intern and has since stepped into a full-time role as a Data Analyst within our Risk Management + Commercial Insurance department. In her role, Talia produces, supports and maintains a collection of analytics reports in partnership with client services for the MJ Risk Management + Commercial Insurance team.
Prior to joining MJ, Talia grew her passion for data and analytics during her time at Butler University, where she earned her degree in Statistics. Armed with this knowledge, her current responsibilities include writing data queries, interpreting results and displaying her findings in an easily digestible format using MJ’s proprietary analytics tool, APERTURE®. Her favorite part about MJ is the ever-expanding knowledge she gains about the insurance industry.
Related Blogs
Employer Response to Pharma Shifts
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More
The MJ Foundation Awards $55,000 to Nashville Nonprofits Team Chad, Pathways Kitchen, and UpRise Nashville
NASHVILLE (Jan. 26, 2026) – The MJ Charitable Foundation (the MJ Foundation) has made major gifts to three Nashville nonprofits as part of its ...
Read More
Major Federal PBM Reforms Enacted as DOL Proposes New PBM Fee-Disclosure Rule
Federal oversight efforts directed at the pharmaceutical benefit manager (PBM) industry have expanded in recent years, culminating in several significant actions. On Feb. 3, ...
Read More